Snowball logo
logo
ERGO

Entia Biosciences Inc

ERGO • PINK
$0.001$0.00  (0%)
Estimate
Beta
28.21
About the company
Ticker
ERGO
ISIN
US29481Q1094
Country
United States of America
Sector (GICS)
Healthcare
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Frequently asked questions

What sector does Entia Biosciences Inc (ERGO) operate in?

Entia Biosciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Entia Biosciences Inc (ERGO) current stock price?

As of the latest data, Entia Biosciences Inc stock price is $0.00, with a previous close of $0.00.

What is Entia Biosciences Inc (ERGO) current market capitalization?

Entia Biosciences Inc market cap is approximately 33.66 thousand.

Does Entia Biosciences Inc (ERGO) pay dividends?

No. Entia Biosciences Inc does not pay a dividend.

What is Entia Biosciences Inc (ERGO) beta (volatility) score?

Entia Biosciences Inc has a beta of 28.210, indicating very high volatility compared to the market.